SecurMed UK, the non-profit organisation that will manage the UK’s Medicines Verification System, has appointed Arvato Systems to meet its obligations under the falsified medicines directive (FMD) and associated delegated regulation.
Letter of intent
A letter of intent has been entered into by SecurMed UK and Arvato Systems, which will see the latter implement the IT solution for the UK. This appointment represents a significant milestone in the UK’s journey to meeting the EU FMD and associated delegated regulatory obligations by February 2019.
SecurMed UK works under the supervision of the UK national competent authorities — MHRA and Department of Health. It has been incorporated by the principal supply chain stakeholder associations [Association of British Pharmaceutical Industry (ABPI), British Generic Manufacturers Association (BGMA), British Association of European Pharmaceutical Distributors (BAEPD), Healthcare Distribution Association (HDA), National Pharmacy Association (NPA) and Company Chemists’ Association (CCA)] as required by the FMD.
Arvato Systems has been chosen as an official service provider by the European Medicines Verification Organisation (EMVO)